1,182
Views
15
CrossRef citations to date
0
Altmetric
Articles

Vancomycin concentrations in the cervical spine after intravenous administration: results from an experimental pig study

, , , , , , & show all

  • Al-Nammari S S, Lucas J D, Lam KS. Hematogenous methicillin-resistant Staphylococcus aureus spondylodiscitis. Spine (Phila Pa 1976) 2007; 32(22): 2480–6.
  • Alini M, Eisenstein S M, Ito K, Little C, Kettler A A, Masuda K, et al. Are animal models useful for studying human disc disorders/degeneration? Eur Spine J 2008; 17(1): 2–19.
  • Bryson D J, Morris D L, Shivji F S, Rollins K R, Snape S, Ollivere B J. Antibiotic prophylaxis in orthopaedic surgery: difficult decisions in an era of evolving antibiotic resistance. Bone Joint J 2016; 98-B(8): 1014–19.
  • Bue M, Birke-Sorensen H, Thillemann T M, Hardlei T F, Soballe K, Tottrup M. Single-dose pharmacokinetics of vancomycin in porcine cancellous and cortical bone determined by microdialysis. Int J Antimicrob Agents 2015; 46(4): 434–8.
  • Bue M, Hanberg P, Koch J, Jensen L K, Lundorff M, Aalbaek B, et al. Single-dose bone pharmacokinetics of vancomycin in a porcine implant-associated osteomyelitis model. J Orthop Res 2018a; 36(4): 1093–1098
  • Bue M, Tottrup M, Hanberg P, Langhoff O, Birke-Sorensen H, Thillemann T M, et al. Bone and subcutaneous adipose tissue pharmacokinetics of vancomycin in total knee replacement patients. Acta Orthop 2018b; 89(1): 95–100
  • Conaughty J M, Chen J, Martinez O V, Chiappetta G, Brookfield K F, Eismont F J. Efficacy of linezolid versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus discitis: a controlled animal model. Spine (Phila Pa 1976) 2006; 31(22): E830–2.
  • Deyo R A, Nachemson A, Mirza S K. Spinal-fusion surgery: the case for restraint. N Engl J Med 2004; 350(7): 722–6.
  • EUCAST. European Committee on Antimicrobial Susceptibility Testing. European 2017; data from the EUCAST MIC distribution website. https://mic.eucast.org/Eucast2/SearchController/search.jsp?action=init
  • Fang A, Hu S S, Endres N, Bradford D S. Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 2005; 30(12): 1460–5.
  • Gaynes R P, Culver D H, Horan T C, Edwards J R, Richards C, Tolson J S. Surgical site infection(SSI) rates in the United States, 1992–1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis 2001; 33(Suppl. 2): S69–S77.
  • Gouliouris T, Aliyu S H, Brown N M. Spondylodiscitis: update on diagnosis and management. J Antimicrob Chemother 2010; 65(Suppl 3): iii11–24.
  • Hanberg P, Bue M, Birke Sorensen H, Soballe K, Tottrup M. Pharmacokinetics of single-dose cefuroxime in porcine intervertebral disc and vertebral cancellous bone determined by microdialysis. Spine J 2016; 16(3): 432–8.
  • Hutschala D, Skhirtladze K, Kinstner C, Zeitlinger M, Wisser W, Jaeger W, et al. Effect of cardiopulmonary bypass on regional antibiotic penetration into lung tissue. Antimicrob Agents Chemother 2013; 57(7): 2996–3002.
  • Joukhadar C, Frossard M, Mayer B X, Brunner M, Klein N, Siostrzonek P, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 2001; 29(2): 385–91.
  • Joukhadar C, Muller M. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin Pharmacokinet 2005; 44(9): 895–913.
  • Komatsu M, Takahata M, Sugawara M, Takekuma Y, Kato T, Ito M, et al. Penetration of linezolid into rabbit intervertebral discs and surrounding tissues. Eur Spine J 2010; 19(12): 2149–55.
  • Landersdorfer C B, Bulitta J B, Kinzig M, Holzgrabe U, Sorgel F. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations. Clin Pharmacokinet 2009; 48(2): 89–124.
  • Mangram A J, Horan T C, Pearson M L, Silver L C, Jarvis W R. Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999; 27(2): 97–132; quiz 3-4; discussion 96.
  • Muller M. Science, medicine, and the future: microdialysis. BMJ 2002; 324(7337): 588–91.
  • Murphy E P, Curtin M, Shafqat A, Byrne F, Jadaan M, Rahall E. A review of the application of vancomycin powder to posterior spinal fusion wounds with a focus on side effects and infection: a prospective study. Eur J Orthop Surg Traumatol 2017; 27(2): 187–91.
  • Pea F. Penetration of antibacterials into bone: what do we really need to know for optimal prophylaxis and treatment of bone and joint infections? Clin Pharmacokinet 2009; 48(2): 125–7.
  • Roberts S, Evans H, Trivedi J, Menage J. Histology and pathology of the human intervertebral disc. J Bone Joint Surg Am 2006; 88 Suppl. 2: 10–14.
  • Rybak M, Lomaestro B, Rotschafer J C, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66(1): 82–98.
  • Scheller D, Kolb J. The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples. J Neurosci Methods 1991; 40(1): 31–8.
  • Schintler M V, Traunmuller F, Metzler J, Kreuzwirt G, Spendel S, Mauric O, et al. High fosfomycin concentrations in bone and peripheral soft tissue in diabetic patients presenting with bacterial foot infection. J Antimicrob Chemother 2009; 64(3): 574–8.
  • Scuderi G J, Greenberg S S, Banovac K, Martinez O V, Eismont F J. Penetration of glycopeptide antibiotics in nucleus pulposus. Spine (Phila Pa 1976) 1993; 18(14): 2039–42.
  • Smith J S, Shaffrey C I, Sansur C A, Berven S H, Fu K M, Broadstone P A, et al. Rates of infection after spine surgery based on 108,419 procedures: a report from the Scoliosis Research Society Morbidity and Mortality Committee. Spine (Phila Pa 1976) 2011; 36(7): 556–63.
  • Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007; 60(4): 788–94.
  • Stolle L B, Arpi M, Holmberg-Jorgensen P, Riegels-Nielsen P, Keller J. Application of microdialysis to cancellous bone tissue for measurement of gentamicin levels. J Antimicrob Chemother 2004; 54(1): 263–5.
  • Tottrup M, Bibby B M, Hardlei T F, Bue M, Kerrn-Jespersen S, Fuursted K, et al. Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model. Antimicrob Agents Chemother 2015; 59(1): 67–75.
  • Tottrup M, Bue M, Koch J, Jensen L K, Hanberg P, Aalbaek B, et al. Effects of implant-associated osteomyelitis on cefuroxime bone pharmacokinetics: assessment in a porcine model. J Bone Joint Surg Am 2016; 98(5): 363–9.
  • Whiteside L A. Prophylactic peri-operative local antibiotic irrigation. Bone Joint J 2016; 98-B(1 Suppl A): 23–6.